|
IL10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.034500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.503000E-03 |
| Normal-vs-Stage2 |
6.060000E-02 |
| Normal-vs-Stage3 |
8.215000E-01 |
| Normal-vs-Stage4 |
6.083400E-01 |
| Stage1-vs-Stage2 |
2.389000E-01 |
| Stage1-vs-Stage3 |
9.616100E-03 |
| Stage1-vs-Stage4 |
1.682190E-01 |
| Stage2-vs-Stage3 |
6.703900E-02 |
| Stage2-vs-Stage4 |
4.722300E-02 |
| Stage3-vs-Stage4 |
4.607200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.021750E-03 |
| Normal-vs-AfricanAmerican |
7.937800E-02 |
| Normal-vs-Asian |
6.266200E-01 |
| Caucasian-vs-AfricanAmerican |
8.790800E-01 |
| Caucasian-vs-Asian |
4.938600E-01 |
| AfricanAmerican-vs-Asian |
3.961400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.411100E-04 |
| Normal-vs-Female |
2.822200E-02 |
| Male-vs-Female |
9.446200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.533380E-01 |
| Normal-vs-Extreme_Weight |
3.003800E-03 |
| Normal-vs-Obese |
9.954100E-02 |
| Normal-vs-Extreme_Obese |
3.133400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.071350E-01 |
| Normal_Weight-vs-Obese |
7.969600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.559510E-02 |
| Extreme_Weight-vs-Obese |
1.879200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.89740000000294E-05 |
| Obese-vs-Extreme_Obese |
9.583000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.628600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.748140E-02 |
| Normal-vs-Age(61-80Yrs) |
6.750600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.274800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.551400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.229700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.990820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.118600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.516800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.501800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.818500E-03 |
| Normal-VS-Type2 PRCC |
1.410440E-02 |
| Normal-VS-KIRP CIMP |
4.682400E-01 |
| Normal-VS-Unclassified PRCC |
4.483100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.291800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.235700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.798980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.155300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.611970E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.362970E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.556200E-02 |
| Normal-vs-N1 |
6.218200E-01 |
| Normal-vs-N2 |
7.611000E-01 |
| N0-vs-N1 |
5.378200E-02 |
| N0-vs-N2 |
5.600800E-01 |
| N1-vs-N2 |
9.580200E-01 |
|
|
